Planning for Co-development of Companion Diagnostics

Donna Roscoe, PhD, from the Division of Molecular Genetics and Pathology
Office of In Vitro Diagnostics and Radiological Health at CDRH, discusses points to consider when planning for companion diagnostics including use of investigational tests, how trial design can impact indication, common pitfalls, and how to obtain regulatory feedback.
Learn more at:
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.  

Upcoming Training –
SBIA Listserv –
SBIA 2021 Playlist –
SBIA LinkedIn:
SBIA Training Resources –
Twitter –
Email –  
Phone – (301) 796-6707 I (866) 405-5367


Related Posts

Privacy Preferences
When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Here you can change your privacy preferences. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.